871
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Different expression of miR-29b and VEGFA in glioma

, , , , &
Pages 1927-1932 | Received 13 Sep 2015, Accepted 19 Oct 2015, Published online: 30 Nov 2015

Figures & data

Figure 1. The relation between miR-29b and VEGFA.

Figure 1. The relation between miR-29b and VEGFA.

Figure 2. Expression of circulating miR-29b and VEGFA in glioma cases and healthy controls. (A) Expression of circulating miR-29b in stages I and II, stages III and IV glioma cases and healthy controls. (B) Expression of circulating VEGFA in stages I and II, stages III and IV glioma cases and healthy controls.

Figure 2. Expression of circulating miR-29b and VEGFA in glioma cases and healthy controls. (A) Expression of circulating miR-29b in stages I and II, stages III and IV glioma cases and healthy controls. (B) Expression of circulating VEGFA in stages I and II, stages III and IV glioma cases and healthy controls.

Table I. Correlation of serum miR-29b and VEGFA expression with clinicopathological features of glioma.

Figure 3. The association between circulating miR-29b and VEGFA in glioma cases.

Figure 3. The association between circulating miR-29b and VEGFA in glioma cases.

Figure 4. ROC curves of circulating miR-29b and VEGFA for the diagnosis of glioma.

Figure 4. ROC curves of circulating miR-29b and VEGFA for the diagnosis of glioma.

Figure 5. The circulating miR-29b and VEGFA level of pre- and post-operation of the glioma patients.

Figure 5. The circulating miR-29b and VEGFA level of pre- and post-operation of the glioma patients.

Table II. Clinicopathological features and serum biomarkers as risk factors of glioma.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.